• Research Technician I-II, Hematopoiesis

    Job ID
    Regular Full-Time
    Fred Hutchinson Cancer Research Center
    Laboratory Research Sciences
  • Overview

    Cures Start Here. At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Careers Start Here.


    The Silberstein Lab, a newly-established hematopoiesis laboratory led by a physician-scientist is seeking to recruit a research technician who is interested in pursuing laboratory-based research project. The laboratory is located at Fred Hutchinson Cancer Research Center in Seattle.


    The main goal of the laboratory is to combine basic stem cell biology and clinically relevant mouse models in order to develop new therapeutic approaches to promote HSC function in bone marrow failure and to enhance hematopoietic reconstitution post-transplant. We are particularly interested in using microenvironment-derived molecules as drugs or therapeutic targets, and have identified several novel niche factors using proximity-based single cell analysis as a discovery strategy (for details, please see Silberstein et al, Cell Stem Cell 2016, Goncalves, Silberstein et al, Cell 2016).


    A successful candidate will be able to assist with 1) cell culture, 2) stem cell expansion studies and 3) development of stem cell enrichment protocols. The position may involve additional responsibilities, such as processing of primary tissue samples, and culture/analysis of cells infected with HIV and related viruses. The candidate should be motivated to participate in sample collection and procession from preclinical modeling experiments. This position affords the motivated technician an opportunity to develop/utilize both tissue culture and molecular biology skills.


    • Candidates should submit a cover letter explaining specific interest in the position and prior research experience.
    • A bachelor’s degree in biological science and 1 – 2 years of laboratory experience outside of coursework. M.S. Degree is also acceptable in lieu of additional experience.
    • Must be highly motivated, have a high level of initiative, work carefully with close attention to detail, and keep detailed records.
    • Capable of working independently as part of a multi-disciplinary team.
    • Excellent organizational, written communication, and oral communication skills.
    • Previous experience in gene therapy/gene editing, qPCR, basic bioinformatics, flow cytometry, flow sorting, cell separation techniques, murine models, and hematopoietic stem cell culture is desired, but not required.

    Our Commitment to Diversity

    We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We are proud to be an Equal Opportunity and VEVRAA Employer. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. If due to a disability you need assistance/and or a reasonable accommodation during the application or recruiting process, please send a request to our Employee Services Center at escmail@fredhutch.org or by calling 206-667-4700.


    Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
    Share on your newsfeed